North America holds 42% of global pet ct scanning services revenue in 2025, worth USD 0.903 billion, and no other region comes close. By 2034 its revenue reaches USD 1.573 billion. The United States alone is the largest single country market at USD 0.722 billion in 2025, or 33.58% of global revenue, so one country supplies most of what the region earns.
Market size and the regional spread
The global market was valued at USD 2.15 billion in 2025. It is projected to grow from USD 2.3 billion in 2026 to USD 4.25 billion by 2034, a compound annual growth rate of 7.98% across the forecast period. Contrive Datum Insights presents these figures in its Pet Ct Scanning Services Market report, which covers 2026-2034.
PET-CT scanning services combine positron emission tomography and X-ray computed tomography in a single hybrid procedure, used mostly to stage, monitor and assess treatment response in oncology, with cardiology and neurology behind it. The category covers the scan itself, delivered through hospital imaging suites, standalone diagnostic centers and mobile units, plus the maintenance and software services that keep scanners running. Buyers include hospital radiology and nuclear medicine departments, independent imaging chains, and operators that sell scanning capacity to health systems without their own hybrid scanners.
Asia Pacific is the region gaining ground. Its share of global revenue climbs from 22% in 2025 to 28% in 2034, as revenue grows from USD 0.473 billion to USD 1.19 billion. Middle East and Africa stays the smallest region throughout, at 4% of 2025 revenue and 4% by 2034, so its position barely shifts while the larger regions trade share.
The segment picture is one of a large incumbent line and faster-growing challengers:
- By type, Positron Emission Tomography (PET) Scanner held 63.02% of 2025 revenue, worth USD 1.355 billion, but grows at 7.4%, a little under the market. X-ray Computed Tomography (CT) Scanner grows at 8.91%, the fastest type line, lifting its share from 36.98% to 40%.
- By application, Oncology led with 58% of revenue at USD 1.247 billion, while Neurology grows fastest at 10.23%.
- By end user, Hospitals led with 52% at USD 1.118 billion; Academic & Research Institutes grows fastest at 9.03%.
- By component, Scanning Services led with 74% at USD 1.591 billion, and Software & Data Management Services grows fastest at 12.84%.
- By deployment model, Fixed/Hospital-based Scanning Centers led with 82% at USD 1.763 billion, while Mobile PET-CT Scanning Services grows fastest at 10.85%.
What could erode the lead
North America benefits from the same force that lifts the whole market: rising cancer incidence and oncology imaging demand, which the study rates as the largest single contributor to growth. The exposure is on cost. High capital and operating cost limiting adoption in price-sensitive markets is expected to hold growth back, and those are the markets where Asia Pacific is building its larger share.
The study's scenarios show how much depends on policy. Its bull case assumes faster hybrid scanner replacement cycles and broader reimbursement for oncology PET-CT in markets outside the United States, Germany and Japan. That would take 2034 revenue to USD 4.675 billion against the USD 4.25 billion base case, and it would widen demand beyond the markets that anchor today's revenue. The bear case puts 2034 revenue at USD 3.825 billion. In either direction, the regional ranking in 2034 depends on whether reimbursement and equipment spending spread faster than North America's own growth.
The report segments the market across five axes (type, application, end user, component and deployment model), with revenue and a growth rate for every line in every year from 2020 to 2034. It covers all five regions with country-level breakdowns, the competitive landscape and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.